• Dutasteride: Reproducible Prostate Cell Assays

  2026-08-26

  This scenario-driven guide explains how Dutasteride, SKU A1659, can support reproducible prostate cancer and benign prostatic hyperplasia research workflows. It covers androgen-pathway design, solvent compatibility, dose-response optimization, apoptosis interpretation, and practical vendor-selection criteria for cell viability and proliferation assays.

• Okadaic acid: PP1 Inhibition Workflow Guide

  2026-08-25

  Okadaic acid (SKU A4540) provides a controlled way to inhibit PP2A predominantly at low nanomolar concentrations and PP1 at higher concentrations for phosphorylation, apoptosis, and signal-transduction experiments. It should be used in validated biochemical or cellular workflows with vehicle controls and assay-specific optimization, not as a clinical or therapeutic intervention.

• T-5224 and AP-1: From Arthritis to Neuroinflammation

  2026-08-25

  T-5224, a selective C-Fos/AP-1 inhibitor, offers translational researchers a way to test whether AP-1 links inflammatory signaling with tissue remodeling and neuroinflammatory sensitization. This article connects established arthritis evidence with the Ca2+-CGRP/SP-Piezo2 findings reported in trigeminal neuralgia while clearly separating validated data from forward-looking hypotheses.

• Oteseconazole (VT-1161): From CYP51 to Translation

  2026-08-24

  A mechanistic and translational framework for evaluating Oteseconazole (VT-1161) as a selective Candida CYP51 inhibitor, with practical assay guidance, resistance context, exposure considerations, and strategic limitations beyond a conventional product page.

• GST-Mediated Resistance in M. usitatus

  2026-08-23

  The reference study identifies MuGSTs1 and GST-mediated antioxidant defense as important contributors to lambda-cyhalothrin resistance in Megalurothrips usitatus. By inhibiting GST with diethyl maleate, the authors linked weakened antioxidant capacity with greater insecticide sensitivity, providing a mechanistic framework for resistance research.

• Spatially Concentrated ABEs Correct PLP1 Mutations

  2026-08-22

  This study introduces spatially concentrated adenine base editors that improve editing in oligodendrocytes by locally enriching the TadA* deaminase at genomic targets rather than simply increasing its catalytic activity. An AAV-compatible compact editor corrected the PLP1 A243V mutation, improved PLP localization, and rescued myelination-related phenotypes while reducing transcriptome-wide RNA off-target effects.

• MK-571: A Causal Map for Inflammation Assays

  2026-08-21

  MK-571 (L-660,711) is more than a leukotriene pathway probe: its receptor and MRP1/ABCC1 activities require deliberate assay deconvolution. This guide connects respiratory pharmacology with macrophage redox protection while defining practical controls for interpretable results.

• Fasudil (HA-1077) HCl: ROCK Inhibitor Guide

  2026-08-21

  Fasudil (HA-1077) HCl provides a practical chemical probe for Rho/ROCK pathway inhibition, with applications spanning cancer-cell proliferation, migration, and apoptosis assays. This workflow-focused guide covers dose design, pathway validation, comparative use with Hippo-pathway studies, and troubleshooting for reproducible experiments.

• SPOP Molecular Glue Degradation Activates STING in Melanoma

  2026-08-20

  This study identifies SPOP as a melanoma-promoting E3 ligase that removes the innate immune sensor STING through CK1γ-dependent recognition. It further shows that SPOP inhibitors can behave as molecular glues, degrading CBX4, increasing DNA damage, and improving responses to immune checkpoint blockade and CD19-CAR-T therapy in mouse models.

• PF-562271 HCl and the Metastatic Niche

  2026-08-20

  PF-562271 HCl is a selective FAK/Pyk2 inhibitor for investigating adhesion, migration, tumor growth, and metastatic biology. This article connects target-proximal FAK phosphorylation inhibition with emerging evidence on circulating cancer-associated macrophage-like cells, providing a phenotype-aware framework for cancer research assays.

• Cinoxacin Workflows for Gram-Negative UTI Research

  2026-08-19

  Build reproducible Cinoxacin susceptibility, bactericidal, and resistance-selection assays around classic agar, broth, and disk-diffusion evidence. This practical guide separates literature-backed conditions from workflow recommendations so researchers can use a quinolone antibiotic as a focused benchmark for gram-negative aerobic bacteria.

• Cy5 NHS ester(Et): Practical Labeling Guide

  2026-08-19

  Cy5 NHS ester(Et) (SKU A8769) is a water-soluble reagent for covalently tagging primary amino groups in proteins, peptides, and other biomolecules for fluorescence-based detection. It is appropriate for freshly prepared aqueous or DMSO workflows, but not for ethanol-based protocols or long-term storage of dye solutions.

• MK-571 (L-660,711): Mechanism and Benchmarks

  2026-08-18

  MK-571, also called L-660,711, is an orally active cysteinyl leukotriene 1 receptor antagonist with nanomolar affinity. It supports leukotriene-mediated inflammation research, asthma research, and mechanistic studies of MRP1-associated drug transport when receptor and transporter effects are experimentally separated.

• Indole-3-pyruvic Acid: Research Workflows

  2026-08-18

  Indole-3-pyruvic acid supports two distinct experimental use cases: probing auxin biosynthesis in plant and fungal systems, and testing AhR-dependent immune modulation in PBMC and arthritis models. This workflow-centered guide connects benchmark findings with practical controls, handling advice, and troubleshooting strategies.

• Phebestin Targets Aminopeptidases in Malaria

  2026-08-17

  The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial compound active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its stage-spanning activity, persistent post-washout effects, computational target engagement, and efficacy in mouse malaria models support aminopeptidases as promising targets, while leaving important pharmacokinetic and translational questions unresolved.

455 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page